GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
MedPage Today on MSN
GLP-1 Use Linked to Lower Colon Cancer Risk vs Aspirin
Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...
Scientists at EPFL and Johns Hopkins uncover the central role of an enzyme in controlling prostate cancer subtypes and ...
Celcuity Inc. soared on best-in-class Phase 3 breast cancer data. Click to see why I have a Buy rating on CELC due to data, regulatory filings, and potential M&A.
A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may ...
Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.
“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...
A study published in Frontiers in Pharmacology suggested that cannabis products could be used to combat ovarian cancer. A ...
Anthocyanin-rich purple foods contain plant pigments that influence antioxidant and inflammatory pathways and are linked in human and experimental studies to measurable benefits in vascular function ...
Diabetes medications found to influence cancer growth in unexpected ways What if the drugs millions take for diabetes every ...
Techno-Science.net on MSN
Cannabis shows effectiveness against cancer
Scientists are examining the medicinal properties of cannabis, a plant often at the heart of debates. In the laboratory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results